Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

BACKGROUND: Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, opting for active symptom control instead. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibby, Anna C., De Fonseka, Duneesha, Morley, Anna J., Keenan, Emma, Addeo, Alfredo, Smith, Sarah, Edey, Anthony J., Maskell, Nick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723074/
https://www.ncbi.nlm.nih.gov/pubmed/29221485
http://dx.doi.org/10.1186/s12904-017-0255-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723074/
https://www.ncbi.nlm.nih.gov/pubmed/29221485
http://dx.doi.org/10.1186/s12904-017-0255-3

Ejemplares similares